STUDY DESIGN: Retrospective database analysis. OBJECTIVE: To investigate national trends of cervical spine surgical procedures from 2002 to 2011. SUMMARY OF BACKGROUND DATA: There is a paucity of literature assessing the current practice trends and outcomes of cervical spine surgery following the 2008 Food and Drug Administration public health notifications regarding bone morphogenetic protein (BMP) utilization in cervical spine surgical procedures. METHODS: The National Inpatient Sample database was accessed for each year across 2002 to 2011. Patients undergoing anterior cervical fusion, posterior cervical fusion, and posterior cervical decompression were identified. Patient and hospitalization parameters including demographics, BMP utilization, costs, early postoperative outcomes, and mortality were assessed for each surgical cohort. A Pearson correlation coefficient with a 95% confidence interval (P < 0.05) was used to analyze trends in patient and hospital outcome parameters during this 10-year period. RESULTS: A total of 307,188 cervical spine procedures were performed from 2002 to 2011. Both the anterior cervical fusion and posterior cervical fusion cohort demonstrated a statistically significant increase in the number of procedures performed over time (r = +0.9, P < 0.001). A significant uptrend in patient age (r = +1.0, P < 0.001) and comorbidity burden (r = +0.9, P < 0.001) was demonstrated during the studied decade. Overall, BMP utilization (r = +0.7, P = 0.02) also demonstrated a significant increase during this time period, but demonstrated a decline after peaking in 2007. The posterior cervical fusion cohort demonstrated the greatest comorbidity, length of stay, costs, and mortality. CONCLUSION: This study demonstrates that the number of cervical spine procedures has increased between 2002 and 2011, irrespective of the change in BMP utilization after the 2008 Food and Drug Administration warning. Despite an older patient population with greater comorbidities undergoing cervical spine surgeries, hospital length of stay and mortality has not significantly changed. However, we did note a significant increase in costs during this time period. These findings may be related to advances in surgical technology and instrumentation that may be associated with rising hospital costs.
STUDY DESIGN: Retrospective database analysis. OBJECTIVE: To investigate national trends of cervical spine surgical procedures from 2002 to 2011. SUMMARY OF BACKGROUND DATA: There is a paucity of literature assessing the current practice trends and outcomes of cervical spine surgery following the 2008 Food and Drug Administration public health notifications regarding bone morphogenetic protein (BMP) utilization in cervical spine surgical procedures. METHODS: The National Inpatient Sample database was accessed for each year across 2002 to 2011. Patients undergoing anterior cervical fusion, posterior cervical fusion, and posterior cervical decompression were identified. Patient and hospitalization parameters including demographics, BMP utilization, costs, early postoperative outcomes, and mortality were assessed for each surgical cohort. A Pearson correlation coefficient with a 95% confidence interval (P < 0.05) was used to analyze trends in patient and hospital outcome parameters during this 10-year period. RESULTS: A total of 307,188 cervical spine procedures were performed from 2002 to 2011. Both the anterior cervical fusion and posterior cervical fusion cohort demonstrated a statistically significant increase in the number of procedures performed over time (r = +0.9, P < 0.001). A significant uptrend in patient age (r = +1.0, P < 0.001) and comorbidity burden (r = +0.9, P < 0.001) was demonstrated during the studied decade. Overall, BMP utilization (r = +0.7, P = 0.02) also demonstrated a significant increase during this time period, but demonstrated a decline after peaking in 2007. The posterior cervical fusion cohort demonstrated the greatest comorbidity, length of stay, costs, and mortality. CONCLUSION: This study demonstrates that the number of cervical spine procedures has increased between 2002 and 2011, irrespective of the change in BMP utilization after the 2008 Food and Drug Administration warning. Despite an older patient population with greater comorbidities undergoing cervical spine surgeries, hospital length of stay and mortality has not significantly changed. However, we did note a significant increase in costs during this time period. These findings may be related to advances in surgical technology and instrumentation that may be associated with rising hospital costs.
Authors: Phillip Grisdela; Zorica Buser; Anthony D'Oro; Permsak Paholpak; John C Liu; Jeffrey C Wang Journal: Eur Spine J Date: 2017-05-09 Impact factor: 3.134
Authors: Silky Chotai; Scott L Parker; J Alex Sielatycki; Ahilan Sivaganesan; Harrison F Kay; Joseph B Wick; Matthew J McGirt; Clinton J Devin Journal: Eur Spine J Date: 2016-11-24 Impact factor: 3.134
Authors: Joseph E Tanenbaum; Daniel Lubelski; Benjamin P Rosenbaum; Nicolas R Thompson; Edward C Benzel; Thomas E Mroz Journal: Spine J Date: 2016-01-11 Impact factor: 4.166
Authors: Gregory Wyatt Poorman; John Y Moon; Samantha R Horn; Cyrus Jalai; Peter L Zhou; Olivia Bono; Peter G Passias Journal: Int J Spine Surg Date: 2018-08-03
Authors: Rogelio A Coronado; Clinton J Devin; Jacquelyn S Pennings; Oran S Aaronson; Christine M Haug; Erin E Van Hoy; Susan W Vanston; Kristin R Archer Journal: Physiother Theory Pract Date: 2019-10-30 Impact factor: 2.176